All Episodes
|
94
|
Stefan Behrens

Podcast 94: Using AI to Improve Clinical Outcomes with Stefan Behrens, PhD

Mar 27, 2020

Episode Summary

This week, John sits down with Stefan Behrens, PhD, co-founder and CEO of GYANT, an artificial intelligence (AI) driven chat tool to help steer patients to the appropriate site of care. Stefan talks about how AI can improve clinical outcomes, and can help health systems and payers lower costs. Most recently, the GYANT architecture is helping triage patients suspected of contracting COVID-19 at some of the nation’s prominent health systems, including Intermountain.

Episode Notes

This week, John sits down with Stefan Behrens, PhD, co-founder and CEO of GYANT, an artificial intelligence (AI) driven chat tool to help steer patients to the appropriate site of care. Stefan talks about how AI can improve clinical outcomes, and can help health systems and payers lower costs. Most recently, the GYANT architecture is helping triage patients suspected of contracting COVID-19 at some of the nation’s prominent health systems, including Intermountain.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 11, 2026

Darwin's Our Take: OpenAI introduces ChatGPT Health to further integrate users' health information

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.